News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
915 Results
Type
Article (53)
Press Release (862)
Section
Business (269)
Deals (81)
Drug Development (128)
FDA (28)
Job Trends (13)
News (498)
Policy (31)
Tag
Alliances (50)
Approvals (27)
Artificial intelligence (1)
Bankruptcy (2)
Best Places to Work (11)
Bladder cancer (1)
Cancer (10)
Clinical research (124)
Collaboration (1)
Compensation (1)
C-suite (1)
Data (8)
Diagnostics (6)
Earnings (126)
Events (168)
Executive appointments (1)
FDA (30)
Government (3)
Healthcare (16)
Infectious disease (1)
IPO (50)
Job creations (2)
Legal (1)
Lung cancer (1)
Medical device (8)
Medtech (8)
Mergers & acquisitions (31)
NextGen: Class of 2025 (7)
Non-profit (2)
Northern California (4)
Patents (1)
People (88)
Phase I (13)
Phase II (43)
Phase III (66)
Postmarket research (10)
Preclinical (6)
Prostate cancer (4)
Radiopharmaceuticals (1)
Regulatory (31)
Southern California (1)
Startups (4)
United States (41)
Vaccines (1)
Date
Last 7 days (2)
Last 30 days (8)
Last 365 days (72)
2025 (13)
2024 (70)
2023 (58)
2022 (69)
2021 (76)
2020 (110)
2019 (81)
2018 (54)
2017 (42)
2016 (26)
2015 (56)
2014 (54)
2013 (23)
2012 (34)
2011 (30)
2010 (44)
Location
Asia (49)
Australia (6)
California (5)
Europe (126)
Massachusetts (1)
New Jersey (26)
New York (1)
Northern California (4)
Ohio (4)
Pennsylvania (1)
Southern California (1)
Utah (3)
915 Results for "urogen".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
UroGen Pharma to Present at Upcoming Investor Conferences
January 30, 2025
·
1 min read
Press Releases
UroGen Pharma to Present at TD Cowen 45th Annual Health Care Conference
February 24, 2025
·
1 min read
Press Releases
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 7, 2025
March 10, 2025
·
2 min read
Press Releases
UroGen Pharma to Report Fourth Quarter and Full-Year 2024 Financial Results on Monday, March 10, 2025
February 27, 2025
·
1 min read
Business
UroGen Pharma Appoints David Lin as New Chief Commercial Officer
UroGen Pharma Ltd. today announced that David Lin will join UroGen as its Chief Commercial Officer and member of the Executive Leadership Team.
June 3, 2024
·
11 min read
Press Releases
UroGen Advances Long-Term Growth Strategy by Acquiring a Next-Generation Investigational Oncolytic Virus (ICVB-1042) and Announces Multiple Strategic Research Collaborations
February 20, 2025
·
6 min read
Press Releases
UroGen Announces Results from Subgroup Analyses of the Pivotal ENVISION Trial Evaluating Impact of Baseline Tumor Burden and Focality on Response to UGN-102
February 17, 2025
·
9 min read
Deals
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 7, 2024
UroGen Pharma Ltd. today announced the grants of inducement restricted stock units (“RSUs”) and an option (“Option”) to 15 new employees in connection with their employment with UroGen.
June 7, 2024
·
2 min read
Press Releases
UroGen Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102
March 10, 2025
·
19 min read
Pharm Country
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
UroGen Pharma Ltd. announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell its ordinary shares and pre-funded warrants.
June 17, 2024
·
4 min read
1 of 92
Next
